Reconsidering Donor Race in Predicting Allograft and Patient Survival Among Kidney Transplant Recipients

Kelly Chong1, Igor Litvinovich1, Shan Shan Chen1

  • 1Nephrology Division, University of New Mexico, Albuquerque, New Mexico.

Kidney360
|April 4, 2022
PubMed

Insights

Donor race should be removed from kidney transplant models to improve patient and allograft survival. This change could decrease kidney discard rates by reclassifying many high-risk donor kidneys, focusing instead on biological factors.

Area of Science:

  • Nephrology
  • Transplantation immunology
  • Medical ethics

Background:

  • Donor race is a factor in current kidney donor risk assessment models.
  • The use of donor race in predicting transplant outcomes is ethically and scientifically questionable.
  • Current models may contribute to kidney allograft discard.

Purpose of the Study:

  • To evaluate the impact of removing donor race from kidney transplant prediction models.
  • To determine if excluding donor race can reduce kidney allograft discard rates.
  • To advocate for the use of biologic factors over social constructs in predictive modeling.

Main Methods:

  • Analysis of kidney donor data, excluding the variable of donor race.
  • Reclassification of kidneys previously categorized as high-risk based on donor race.
  • Simulation of revised Kidney Donor Risk Index (KDRI) scores.

Main Results:

  • Removing donor race from predictive models may reclassify up to 50% of kidneys currently deemed high-risk.
  • Exclusion of donor race is unlikely to negatively impact patient or allograft survival predictions.
  • Potential for increased utilization of deceased donor kidneys.

Conclusions:

  • Donor race is not a valid predictor of kidney allograft or patient survival and should be removed from risk models.
  • Eliminating donor race from the Kidney Donor Risk Index could significantly reduce kidney discard.
  • Future kidney transplant prediction models must prioritize relevant biological determinants over social constructs.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
67
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
82
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
542
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
527
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
90